|
FISH Test Name |
Chromosome Component |
Genes |
Disease Association |
|
BCR/ABL+9q34 |
9, 22 |
ABL, BCR, ASS |
Chronic Myeloid Leukemia
Acute Lymphocytic Leukemia |
|
MDS panel |
5, 7, 8, 20 |
D5S721-D5S23/CSF1R,D7S486/Cen7,
Cen 8,D20S108 |
Myelodysplastic Syndrome
|
|
CLL panel |
11,12,13,14,17 |
ATM, CCND1(BCL1).
Cen12, D13S319, LAMP1,IgH, p53 |
Chronic Lymphocytic Leukemia
|
|
AML-1/ETO |
8, 21 |
ETO, AML 1 |
Acute Myeloid Leukemia (M2)
|
|
APL |
15, 17 |
PML, RARA |
Acute Promyelocytic Leukemia
(M3) |
|
Mantle Cell Lymphoma |
11, 14 |
CCND1(BCL1), IgH |
Mantle Cell Lymphoma
|
|
Burkitt Lymphoma |
8, 14 |
MYC, Cen 8, IgH |
Burkitt Lymphoma
|
|
Follicular Lymphoma |
14, 18 |
IgH, BCL 2 |
Follicular Lymphoma |
|
MM-MGUS panel |
1,3,5, 9, 13, 14, 17 |
CEB108/T7:1QTEL10,
D5S721-D5S23/CSF1R,
Cen 3, Cen 9, D13S319, LAMP1, IgH, p53
|
Multiple Myeloma
|
|
Reflex MM |
4,11, 14, 16 |
FGFR3, CCND1, IgH, MAF |
Prognostic Indicators in Multiple Myeloma |
|
Inv 16 |
16 |
CBFB |
Acute Myeloid Leukemia
|
|
MLL |
11 |
MLL |
AML and ALL
|
|
MALT1 |
18 |
MALT 1 |
B-cell Non-Hodgkin Lymphoma, Margin Zone B-cell Lymphoma |
|
BCL6 |
3 |
BCL6 |
B-cell Lymphoma |
|
ALK |
2 |
ALK |
Anaplasic Large Cell Lymphoma |
|
PDGFRa |
4 |
FIPL1L1/CHIC2/PDGFRa |
HES, CEL |
|
MM t(4;14) |
4,14 |
FGFR3, IgH |
Multiple Myeloma, MGUS |
|
MM t(11;14) |
11,14 |
CCND1 (BCL1), IgH |
Multiple Myeloma, MGUS |
|
MM t(14;16) |
14,16 |
IgH, MAF |
Multiple Myeloma, MGUS |
|
IgH |
14 |
IgH |
Lymphoma |
|
AML panel |
5, 7, 8, 11, 15, 16, 17, 21 |
D5S721-D5S23/CSF1R,
D7S486/Cen 7, Cen 8,
ETO, MLL, PML, CBFB, RARA, AML-1 |
Acute Myeloid Leukemia |
|
MALT t(11;18) |
11,18 |
AP12, MALT1 |
MALT Lymphoma |
|
MYC |
8 |
MYC |
B-ALL, NHL |
|
NHL |
2,3,8,11,14,18 |
ALK, BCL6, MYC, Cen 8, CCND1(BCL1), IgH, BCL2, MALT1 |
Non-Hodgkin's Lymphoma |
|
Bladder Cancer |
3, 7, 17, 9 |
Cen 3, Cen 7, Cen 17, 9p21 |
Bladder Cancer |
|
Breast Cancer |
17 |
HER2, Cen 17 |
Breast Cancer
|